- MIT: Potent New Strategies Enhancing COVID-19 RNA Vaccines
- Long-COVID Found to Have Surprising Connection with Common Cold
- AI Accelerates Deep Brain Stimulation for Treatment-Resistant Depression
- Fentanyl and Stimulant Abuse Lead to the 4th Wave of Overdose Crisis
- New Gene Editing Tool Reduces Accidental Mutations by Over 70%
- What role do Macrophages play in Tumor Immunotherapy?
Will fatty liver develop into cancer?
Will fatty liver develop into cancer? The three words “fatty liver” appear more and more on people’s physical examination reports. Some people are very scared and think this is the prelude to liver cancer; some people don’t care, and think it’s okay to eat less.
Which statement is correct? Why are some fatty livers okay, but some have become cancers?
A recent physical examination revealed fatty liver! Is it serious?
Don’t panic! The “fatty liver” on the physical examination report is usually screened out by ultrasound examination of the liver, which only indicates the presence of excessive fat deposits in the liver.
Steatohepatitis refers to the infiltration of inflammatory cells in the liver and the presence of degeneration and necrosis of liver cells. The above-mentioned pathological changes can only be diagnosed by pathological examination of liver puncture.
It must be noted that fatty liver with normal transaminase may also be steatohepatitis, so it should not be careless just because the transaminase is normal.
If liver function transaminase is repeatedly elevated, combined with metabolic syndrome and insulin resistance, under the intervention of eliminating other liver diseases and giving diet control/exercise, liver function transaminase is still high after 6 months, and liver puncture is required.
Or when auxiliary examinations suggest liver fibrosis, or manifestations of potential liver cirrhosis, liver puncture pathological examinations should also be performed.
Will fatty liver definitely become cirrhosis and liver cancer?
Whether fatty liver will progress is related to the metabolic difference caused by the patient’s own genetic background.
To put it simply, in addition to the patient’s own living habits and the degree of emphasis on the disease, there are also some specific groups of people.
For example, patients with hypertension and diabetes, as well as people who have already developed liver fibrosis, are the main force in the development of liver cirrhosis and liver cancer.
For ordinary fatty liver patients, is it enough to lose weight?
Weight loss can reduce the severity of steatohepatitis, but the weight loss must exceed 10-15% of the basic body weight to achieve the therapeutic effect. If the weight loss goal cannot be achieved, or the complete reversal of fatty liver cannot be achieved after weight loss, medication must be combined.
(source:internet, reference only)